These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8737211)

  • 41. Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study Group.
    Muller DW; Topol EJ; George BS; Kereiakes DJ; Aronson LG; Lee KL; Abbottsmith CW; Ellis SG; Califf RM
    Am J Cardiol; 1990 Oct; 66(10):796-801. PubMed ID: 2220575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
    White HD; Rivers JT; Maslowski AH; Ormiston JA; Takayama M; Hart HH; Sharpe DN; Whitlock RM; Norris RM
    N Engl J Med; 1989 Mar; 320(13):817-21. PubMed ID: 2494454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary angioplasty after intravenous streptokinase in acute myocardial infarction: influence of restenosis on clinical outcome and left ventricular function.
    Leisch F; Kerschner K; Harringer W; Schützenberger W
    Clin Cardiol; 1990 Apr; 13(4):253-9. PubMed ID: 2350911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F
    Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666
    [No Abstract]   [Full Text] [Related]  

  • 45. Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.
    Spiecker M; Windeler J; Vermeer F; Michels R; Seabra-Gomes R; vom Dahl J; Kerber S; Verheugt FW; Westerhof PW; Bär FW; Nixdorff U; Barth H; Hopkins GR; von Fisenne MJ; Meyer J
    Am Heart J; 1999 Sep; 138(3 Pt 1):518-24. PubMed ID: 10467203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.
    Marino P; Zanolla L; Zardini P
    J Am Coll Cardiol; 1989 Nov; 14(5):1149-58. PubMed ID: 2681320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.
    de Boer MJ; Reiber JH; Suryapranata H; van den Brand MJ; Hoorntje JC; Zijlstra F
    Eur Heart J; 1995 Oct; 16(10):1347-55. PubMed ID: 8746902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
    Kereiakes DJ; Califf RM; George BS; Ellis S; Samaha J; Stack R; Martin LH; Young S; Topol EJ
    Am Heart J; 1991 Aug; 122(2):390-9. PubMed ID: 1907087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome.
    Dudek D; Rakowski T; El Massri N; Sorysz D; Zalewski J; Legutko J; Dziewierz A; Rzeszutko L; Zmudka K; Piwowarska W; De Luca G; Kaluza GL; Janion M; Dubiel JS
    Int J Cardiol; 2008 Mar; 124(3):326-31. PubMed ID: 17433468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years: a single-center, open, randomized trial.
    Minai K; Horie H; Takahashi M; Nozawa M; Kinoshita M
    Am Heart J; 2002 Mar; 143(3):497-505. PubMed ID: 11868057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase.
    Khattar RS; Basu SK; Raval U; Senior R; Lahiri A
    Am J Cardiol; 1996 Jul; 78(2):136-41. PubMed ID: 8712132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary angioplasty vs thrombolysis in acute MI.
    Millard PS
    J Fam Pract; 1997 Jul; 45(1):21-2. PubMed ID: 9228907
    [No Abstract]   [Full Text] [Related]  

  • 55. Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction.
    Res JC; Simoons ML; van der Wall EE; van Eenige MJ; Vermeer F; Verheugt FW; Wijns W; Braat S; Remme WJ; Serruys PW
    Br Heart J; 1986 Nov; 56(5):414-21. PubMed ID: 3539162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patency and reinfarction in late-entry myocardial infarct patients treated with reperfusion therapy.
    van 't Hof AW; Zijlstra F; de Boer MJ; Liem AL; Hoorntje JC; Suryapranata H
    Angiology; 1997 Mar; 48(3):215-22. PubMed ID: 9071196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis.
    Vlahović A; Nesković AN; Dekleva M; Putniković B; Popović ZB; Otasević P; Ostojić M
    Am Heart J; 2004 Jul; 148(1):e1. PubMed ID: 15215810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved left ventricular function in myocardial infarction following intravenous thrombolytic therapy with acylated plasminogen activator.
    Ovsyshcher I; Silber H; Hausman MI; Margolis G; Gueron M
    Angiology; 1990 Feb; 41(2):133-8. PubMed ID: 2407157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.
    Gillis JC; Goa KL
    Pharmacoeconomics; 1996 Sep; 10(3):281-310. PubMed ID: 10163575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.